Healthcare Industry News: cervical spine
News Release - October 26, 2016
RTI Surgical Announces Additional 510(k) Clearance for the Streamline(R) OCT SystemALACHUA, Fla.--(Healthcare Sales & Marketing Network)--RTI Surgical (RTI) (RTIX), a global surgical implant company, is pleased to announce a recent 510(k) clearance for the Streamline OCT Occipito-Cervico-Thoracic System. This clearance expands the indication for polyaxial screw placement to include the cervical spine, and also includes clearance for a dual diameter transition rod.
The system’s newly expanded indications span from the Occiput to T3, but additional levels of fixation can be accomplished by connecting to other RTI pedicle screw systems through the newly cleared transition rod or currently available rod-to-rod connectors.
“We are excited about the launch of the transition rod, as well as the receipt of the posterior cervical screw indication,” said Brian Hutchison, chief executive officer. “These updates to our Streamline OCT System reflect our passion to deliver surgical solutions that provide a higher standard of patient care and deliver the highest value to our customers.”
About RTI Surgical Inc.
RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about anticipated financial results, growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting RTI's website at www.rtix.com or the SEC's website at www.sec.gov.
Source: RTI Surgical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.